{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:15:36Z","timestamp":1790014536526,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Calcium"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.ceca.2014.07.004","type":"journal-article","created":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T12:15:14Z","timestamp":1405685714000},"page":"195-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3104-3700","authenticated-orcid":false,"given":"Cornelia","family":"Roesl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisaku","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Schiemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Stowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ceca.2014.07.004_bib0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ceca.2004.08.001","article-title":"Intracellular Ca2+ dynamics in malignant hyperthermia and central core disease: established concepts, new cellular mechanisms involved","volume":"37","author":"Avila","year":"2005","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ceca.2014.07.004_bib0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ceca.2014.07.004_bib0015","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2217\/14622416.9.11.1657","article-title":"Malignant hyperthermia: a pharmacogenetic disorder","volume":"9","author":"Stowell","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ceca.2014.07.004_bib0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/geno.1996.0238","article-title":"The structural organization of the human skeletal muscle ryanodine receptor (RYR1) gene","volume":"34","author":"Phillips","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.ceca.2014.07.004_bib0025","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/bja\/56.11.1267","article-title":"A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group","volume":"56","author":"European Malignant Hyperpyrexia Group","year":"1984","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ceca.2014.07.004_bib0030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1213\/00000539-198910000-00015","article-title":"Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group","volume":"69","author":"Larach","year":"1989","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ceca.2014.07.004_bib0035","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.nmd.2005.06.008","article-title":"Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders","volume":"15","author":"Treves","year":"2005","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ceca.2014.07.004_bib0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00540-009-0746-3","article-title":"Functional analysis of ryanodine receptor type 1 p.R2508C mutation in exon 47","volume":"23","author":"Migita","year":"2009","journal-title":"J. Anesth."},{"key":"10.1016\/j.ceca.2014.07.004_bib0045","doi-asserted-by":"crossref","first-page":"E575","DOI":"10.1002\/humu.20991","article-title":"Functional characterization of ryanodine receptor (RYR1) sequence variants using a metabolic assay in immortalized B-lymphocytes","volume":"30","author":"Zullo","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ceca.2014.07.004_bib0050","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.nmd.2004.03.011","article-title":"Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model","volume":"14","author":"Wehner","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ceca.2014.07.004_bib0055","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/oxfordjournals.bja.a013478","article-title":"Malignant hyperthermia in infancy and identification of novel RYR1 mutation","volume":"84","author":"Chamley","year":"2000","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ceca.2014.07.004_bib0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jocn.2011.05.010","article-title":"A study of a family with the skeletal muscle RYR1 mutation (c.7354C>T) associated with central core myopathy and malignant hyperthermia susceptibility","volume":"19","author":"Taylor","year":"2012","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.ceca.2014.07.004_bib0065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/bja\/60.3.287","article-title":"Diagnosis of susceptibility to malignant hyperthermia in man","volume":"60","author":"Ording","year":"1988","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ceca.2014.07.004_bib0070","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1399-6576.1997.tb04820.x","article-title":"In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group","volume":"41","author":"Ording","year":"1997","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.ceca.2014.07.004_bib0075","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/0310057X1103900514","article-title":"Safety of exposure of malignant hyperthermia non-susceptible patients and their relatives to anaesthetic triggering agents","volume":"39","author":"Pollock","year":"2011","journal-title":"Anaesth. Intensive Care"},{"key":"10.1016\/j.ceca.2014.07.004_bib0080","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1097\/ALN.0b013e3181d69283","article-title":"Functional studies of RYR1 mutations in the skeletal muscle ryanodine receptor using human RYR1 complementary DNA","author":"Sato","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ceca.2014.07.004_bib0085","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1083\/jcb.125.6.1275","article-title":"Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy","volume":"125","author":"Rando","year":"1994","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ceca.2014.07.004_bib0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02796399","article-title":"Modified nutrient medium MCDB 151, defined growth factors, cholera toxin, pituitary factors, and horse serum support epithelial cell and suppress fibroblast proliferation in primary cultures of rat ventral prostate cells","volume":"18","author":"McKeehan","year":"1982","journal-title":"In Vitro"},{"key":"10.1016\/j.ceca.2014.07.004_bib0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1399-0004.2002.620206.x","article-title":"Increased sensitivity to 4-chloro-m-cresol and caffeine in primary myotubes from malignant hyperthermia susceptible individuals carrying the ryanodine receptor 1 Thr2206Met (C6617T) mutation","volume":"62","author":"Wehner","year":"2002","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ceca.2014.07.004_bib0100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1242\/jcs.61.1.289","article-title":"Adaptation of human diploid fibroblasts in vitro to serum from different sources","volume":"61","author":"Zamansky","year":"1983","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ceca.2014.07.004_bib0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0143-4160(03)00072-1","article-title":"The Ile2453Thr mutation in the ryanodine receptor gene 1 is associated with facilitated calcium release from sarcoplasmic reticulum by 4-chloro-m-cresol in human myotubes","volume":"34","author":"Wehner","year":"2003","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ceca.2014.07.004_bib0110","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00279094","article-title":"A routine method for the establishment of permanent growing lymphoblastoid cell lines","volume":"73","author":"Neitzel","year":"1986","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ceca.2014.07.004_bib0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/ALN.0b013e31828cebfe","article-title":"Skeletal muscle ryanodine receptor mutations associated with malignant hyperthermia showed enhanced intensity and sensitivity to triggering drugs when expressed in human embryonic kidney cells","volume":"119","author":"Sato","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ceca.2014.07.004_bib0120","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ab.2007.11.019","article-title":"Identification of ryanodine receptor 1 single-nucleotide polymorphisms by high-resolution melting using the LightCycler 480 System","volume":"374","author":"Grievink","year":"2008","journal-title":"Anal. Biochem."},{"issue":"Pt 1","key":"10.1016\/j.ceca.2014.07.004_bib0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/bj3340079","article-title":"Expression of ryanodine receptors in human embryonic kidney (HEK293) cells","volume":"334","author":"Querfurth","year":"1998","journal-title":"Biochem. J"},{"key":"10.1016\/j.ceca.2014.07.004_bib0130","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1242\/jcs.115.12.2497","article-title":"RyR1 and RyR3 isoforms provide distinct intracellular Ca2+ signals in HEK 293 cells","volume":"115","author":"Rossi","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ceca.2014.07.004_bib0135","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S1734-1140(09)70139-2","article-title":"Commonly used ryanodine receptor activator 4-chloro-m-cresol (4CmC), is also an inhibitor of SERCA Ca2+ pumps","volume":"61","author":"Al-Mousa","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ceca.2014.07.004_bib0140","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1073\/pnas.071048198","article-title":"Excitation-contraction uncoupling by a human central core disease mutation in the ryanodine receptor","volume":"98","author":"Avila","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ceca.2014.07.004_bib0145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1085\/jgp.200308791","article-title":"The pore region of the skeletal muscle ryanodine receptor is a primary locus for excitation-contraction uncoupling in central core disease","volume":"121","author":"Avila","year":"2003","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.ceca.2014.07.004_bib0150","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/01.anes.0000299431.81267.3e","article-title":"Identification and biochemical characterization of a novel ryanodine receptor gene mutation associated with malignant hyperthermia","volume":"108","author":"Anderson","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ceca.2014.07.004_bib0155","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1213\/ANE.0b013e3181cbd815","article-title":"Functional properties of RYR1 mutations identified in Swedish patients with malignant hyperthermia and central core disease","author":"Vukcevic","year":"2010","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ceca.2014.07.004_bib0160","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/bja\/83.6.855","article-title":"Malignant hyperthermia causing Gly2435Arg mutation of the ryanodine receptor facilitates ryanodine-induced calcium release in myotubes","volume":"83","author":"Brinkmeier","year":"1999","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ceca.2014.07.004_bib0165","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/00000542-200606000-00014","article-title":"Characterization of ryanodine receptor-mediated calcium release in human B cells: relevance to diagnostic testing for malignant hyperthermia","volume":"104","author":"McKinney","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ceca.2014.07.004_bib0170","doi-asserted-by":"crossref","first-page":"26332","DOI":"10.1074\/jbc.272.42.26332","article-title":"Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and\/or central core disease","volume":"272","author":"Tong","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2014.07.004_bib0175","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1172\/JCI993","article-title":"Intracellular calcium homeostasis in human primary muscle cells from malignant hyEffect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors, perthermia-susceptible and normal individuals","volume":"101","author":"Censier","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ceca.2014.07.004_bib0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0304-4165(95)00131-X","article-title":"4-Chloro-m-cresol, a potent and specific activator of the skeletal muscle ryanodine receptor","volume":"1289","author":"Herrmann-Frank","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ceca.2014.07.004_bib0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0006-2952(96)00175-X","article-title":"4-Chloro-m-cresol: a specific tool to distinguish between malignant hyperthermia-susceptible and normal muscle","volume":"52","author":"Herrmann-Frank","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ceca.2014.07.004_bib0190","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1074\/jbc.274.9.5995","article-title":"Skeletal muscle type ryanodine receptor is involved in calcium signaling in human B lymphocytes","volume":"274","author":"Sei","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2014.07.004_bib0195","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/BJ20051282","article-title":"Functional properties of ryanodine receptors carrying three amino acid substitutions identified in patients affected by multi-minicore disease and central core disease, expressed in immortalized lymphocytes","volume":"395","author":"Ducreux","year":"2006","journal-title":"Biochem. J"},{"key":"10.1016\/j.ceca.2014.07.004_bib0200","doi-asserted-by":"crossref","first-page":"43838","DOI":"10.1074\/jbc.M403612200","article-title":"Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease","volume":"279","author":"Ducreux","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2014.07.004_bib0205","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1050-1738(01)00067-6","article-title":"Postulated role of inter-domain interaction within the ryanodine receptor in Ca2+ channel regulation","volume":"10","author":"Ikemoto","year":"2000","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.ceca.2014.07.004_bib0210","doi-asserted-by":"crossref","first-page":"d671","DOI":"10.2741\/ikemoto","article-title":"Regulation of calcium release by interdomain interaction within ryanodine receptors","volume":"7","author":"Ikemoto","year":"2002","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ceca.2014.07.004_bib0215","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1002\/j.1460-2075.1995.tb07302.x","article-title":"Ca2+-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor","volume":"14","author":"Takeshima","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.ceca.2014.07.004_bib0220","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1113\/jphysiol.1991.sp018606","article-title":"Large conductance calcium-activated non-selective cation channel in smooth muscle cells isolated from rat portal vein","volume":"437","author":"Loirand","year":"1991","journal-title":"J. Physiol."},{"key":"10.1016\/j.ceca.2014.07.004_bib0225","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0026-895X(25)13345-2","article-title":"Chlorocresol: an activator of ryanodine receptor-mediated Ca2+ release","volume":"44","author":"Zorzato","year":"1993","journal-title":"Mol. Pharmacol."}],"container-title":["Cell Calcium"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143416014001080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143416014001080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:17:50Z","timestamp":1758917870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143416014001080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0143416014001080"],"URL":"https:\/\/doi.org\/10.1016\/j.ceca.2014.07.004","relation":{},"ISSN":["0143-4160"],"issn-type":[{"value":"0143-4160","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility","name":"articletitle","label":"Article Title"},{"value":"Cell Calcium","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ceca.2014.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}